Serum transferrin receptor in the assessment of iron status;Apport du dosage du récepteur soluble de la transferrine

Transfusion Clinique et Biologique

Volumn 18, Issue 1, 2011, Pages 36-39

  Desideri Vaillant C ^a   Galinat, H ^a   Sapin Lory, J ^a   Valero, E ^a   Perennec, V ^a   Lefevre, F ^a  

^a Military Teaching Hospital Clermont Tonnerre   (France)

Author keywords

Anemia; Iron deficiency; Non efficient erythropoiesis; Transferrin receptor

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; IRON; TRANSFERRIN RECEPTOR;

ARTICLE; CELL HYPERPLASIA; ERYTHROID CELL; HEMATOCRIT; INFLAMMATION; IRON DEFICIENCY; PROTEIN BLOOD LEVEL;

ANEMIA, IRON-DEFICIENCY; ANTIGENS, CD; BIOLOGICAL MARKERS; BONE MARROW; C-REACTIVE PROTEIN; ERYTHROCYTE VOLUME; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; HYPERPLASIA; IRON; RECEPTORS, TRANSFERRIN; REFERENCE VALUES; SOLUBILITY; TRANSCRIPTION, GENETIC;

EID: 79952693627     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2010.10.001     Document Type: Article

References (31)

1. Vernet M. Le récepteur de la transferrine rôle dans le métabolisme du fer et intérêt en biologie clinique. Ann Biol Clin 1999, 57(1):9-17.
2. Kohgo Y., Nishisato T., Kondo H., Tsushima N., Niitsu Y., Urushizaki I. Circulating transferring receptor in human serum. Br J Haematol 1986, 64:277-281.
3. Ahn J., Johnstone R.M. Origin of a soluble transferrin receptor. Blood 1993, 81(9):2442-2451.
4. Shih Y.J., Baynes R.D., Hudson B.G., Cook J.D. Characterization and quantification of the circulating forms of serum transferring receptor using domain-specific antibodies. Blood 1993, 81(1):234-238.
5. Gaillard T., Fontan E., Civadier C., Émile E. Pratique d'un nouveau marqueur du diagnostic des déficits martiaux le récepteur soluble de la transferrine. Ann Biol Clin 2001, 58(5):632-635.
6. Cook J.D., Skikne B.S., Baynes R.D. Serum transferrin receptor. Annu Rev Med 1993, 44:63-74.
7. Skikne B.S., Flowers C.H., Cook J.D. Serum transferring receptor: a quantitative measure of tissue iron deficiency. Blood 1990, 75(9):1870-1876.
8. Giraudet P., Le Bourdelles S., Alibay Y., Alexandre J.A. Le récepteur soluble de la transferrine du métabolisme à l'intérêt clinique. Rev Fr Lab 1999, 312:99-104.
9. Doyen C., Sotta C., Revenant M.C. Le récepteur de la transferrine intérêt dans l'exploration du statut martial. Immunoanal Biol Spec 2001, 16:71-77.
10. Choi J.W., Pai S.H. Association between serum transferring receptor concentrations and erythropoietic activities according to body iron status. Ann Clin Lab Sci 2003, 33(3):279-284.
11. Batts K.P. Iron overload syndromes and the liver. Mod Pathol 2007, 20:S31-S39.
12. Freixenet N., Remacha A., Berlanga E., Caixas A., Gimenez-Palop O., Blanco-Vaca F., et al. Results from a screening programme for hereditary hemochromatosis in men with hyperferritinemia. Clin Chim Acta 2009, 400:111-116.
13. Espanel C., Kafando E., Hérault B., Petit A., Hérault O., Binet C. Anémies ferriprives signes d'appel, diagnostic et prise en charge. Transfus Clin Biol 2007, 14:21-27.
14. Ferguson B.J., Skikne B.S., Simpson K.M., Baynes R.D., Cook J.D. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med 1992, 119:285-290.
15. Punnonen K., Irjala K., Rajamäki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997, 89:1052-1057.
16. Weiss G., Goodnough L.T. Anemia of chronic disease. N Engl J Med 2005, 352(10):1011-1023.
17. Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem 2003, 49(10):1573-1578.
18. Ruivard M., Boursiac M., Mareynat G., Sapin A.F., Gerbaud L., Derumeaux H., et al. Diagnostic de la carence en fer évaluation du rapport « récepteur soluble de la transferrine/ferritine ». Rev Med Int 2000, 21:837-883.
19. Nair K.M., Bhaskaram P., Balakrishna N., Ravinder P., Sesikeran B. Response of haemoglobin, serum ferritin and serum transferring receptor during iron supplementation in pregnancy: a prospective study. Nutrition 2004, 20(10):896-899.
20. Kohgo Y., Niitsu Y., Kondo H., Kato J., Tsushima N., Sasaki K., et al. Serum transferring receptor as a new index of erythropoiesis. Blood 1987, 70(56):1955-1958.
21. Huebers H.A., Beguin Y., Pootrakul P., Einspahr D., Finc C.A. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 1990, 75(1):102-107.
22. Uapraset N., Rojnuckarin P., Bhokaisawan N., Settapiboon R., Wacharaprechanont T., Amornsiriwat S., et al. Elevated serum transferrin receptor levels in common types of thalassemia heterozygotes in Southeast Asia: a correlation with genotypes and red cell indices. Clin Chim Acta 2009, 403:110-113.
23. Ong K.H., Tan H.L., Tam L.P., Hawkins C.W., Kuperan P. Accuracy of serum transferrin receptor levels in the diagnosis of iron deficiency among hospital patients in a population with a high prevalence of thalassaemia trait. Int J Lab Hematol 2008, 30:487-493.
24. Skarmoutsou C., Papassotiriou I., Traeger-Synodinos J., Stamou H., Ladis V., Metaxotou-Mavrommati A., et al. Erythroid bone marrow activity and red hemoglobinization in iron-sufficient β-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin content; correlation with genotypes and Hb A2 levels. Haematologica 2003, 88(6):631-636.
25. Ress D.C., Williams T.N., Maitland K., Clegg J.B., Weatherall D.J. Alpha thalassaemia is associated with increased soluble transferrin receptor levels. Br J Haematol 1998, 103:365-369.
26. Singhal A., Cook J., Skikne B., Thomas P., Serjeant B., Serjeant G. The clinical signifiance of serum transferrin receptor levels in sickle cell disease. Br J Haematol 1993, 84:301-304.
27. Lopez-Sall P, Diop PA, Diagne I, Cissé A, Mahou CMS, Sylla-Niang M et al. Apport des récepteurs solubles de la transferrine dans l'évaluation du statut en fer au cours de la drépanocytose homozygote. Ann Biol Clin 2004;62:415-21.
28. Klemow D., Einsphar D., Brown T.A., Flowers C.H., Skikne B.S. Serum transferrin receptor measurements in hematologic malignancies. Am J Hematol 1990, 34:193-198.
29. Beguin Y., Loo M., R'Zik S., Lejeune F., Rorive G., Fillet G. Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood 1993, 82(7):2010-2016.
30. Audran M., Gareau R., Matecki S., Durand F., Chenard C., Sicart M.T., et al. Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Med Sci Sports Ex 1999, 31:639-645.
31. Parisotto R., Wu M., Ashenden M.J., Emslie K.R., Gore C.J., Howe C. Detection of recombinant human erythropoietin abuse in atletes utilizing markers of altered erythropoiesis. Haematologica 2001, 86(2):128-137.